Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04BGT
|
||||
Former ID |
DNC010608
|
||||
Drug Name |
4-propyl-6-m-tolylpyrimidine-2-carbonitrile
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531005] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H15N3
|
||||
Canonical SMILES |
CCCC1=NC(=NC(=C1)C2=CC(=CC=C2)C)C#N
|
||||
InChI |
1S/C15H15N3/c1-3-5-13-9-14(18-15(10-16)17-13)12-7-4-6-11(2)8-12/h4,6-9H,3,5H2,1-2H3
|
||||
InChIKey |
LWTLVKKUNGVFHE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | Inhibitor | [531005] | |
Cathepsin S | Target Info | Inhibitor | [531005] | ||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.